BioCentury
ARTICLE | Financial News

Obalon Therapeutics proposes IPO

September 12, 2016 7:00 AM UTC

Obalon Therapeutics Inc., Carlsbad, Calif. Business: Endocrine/Metabolic Date announced: 2016-09-09 Type: IPO To be raised: Up to $75 million Shares: TBD Price: TBD Underwriters: UBS; Canaccord; Stife...